- Pharmaceutical Products
- Products By Brand Name
- Products By Dosage Form
- Products By Generic Name
- Products By Therapeutic Class
Find a product
Find Generic
Glims M XR
Glimepiride and Metformin Hydrochloride
Description:
Glims M XR is a combination of 2 oral anti-hyperglycemic drugs: Glimepiride, a Sulfonylurea and Metformin, a member of the biguanide class to improve glycemic control in patients with type-2 diabetes mellitus.
Glims M XR is a combination of 2 oral anti-hyperglycemic drugs: Glimepiride, a Sulfonylurea and Metformin, a member of the biguanide class to improve glycemic control in patients with type-2 diabetes mellitus.
Indications:
Glims M is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both Glimepiride and Metformin is appropriate.
Glims M is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both Glimepiride and Metformin is appropriate.
Mode of Action:
The primary mechanism of action of Glimepiride, is to stimulate the release of insulin from functioning pancreatic beta cells. The pharmacologic mechanism of action of Metformin is different from other classes of oral anti-hyperglycemic agents. Metformin decreases hepatic glucose production, decreases intestinal absorption of glucose, and increases peripheral glucose uptake and utilization.
The primary mechanism of action of Glimepiride, is to stimulate the release of insulin from functioning pancreatic beta cells. The pharmacologic mechanism of action of Metformin is different from other classes of oral anti-hyperglycemic agents. Metformin decreases hepatic glucose production, decreases intestinal absorption of glucose, and increases peripheral glucose uptake and utilization.
Other Brands From Same Therapeutic Class
